--2025/Q1-- / 0.000--
--2024/Q4-- / 60.000K--
--2024/Q30.000 / 75.000K--
--2024/Q20.000 / 75.000K--
--------
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ARTV Artiva Biotherapeutics
- 10.620
- -0.060-0.56%
Close Dec 13 16:00 ET
- 10.620
- 0.0000.00%
Post 16:00 ET
257.95MMarket Cap-4.21P/E (TTM)
10.890High10.500Low42.66KVolume10.540Open10.680Pre Close454.58KTurnover0.31%Turnover RatioLossP/E (Static)24.29MShares17.31052wk High1.28P/B147.83MFloat Cap9.68052wk Low--Dividend TTM13.92MShs Float17.310Historical High--Div YieldTTM3.65%Amplitude9.680Historical Low10.656Avg Price1Lot Size
Artiva Biotherapeutics Key Stats
Artiva Biotherapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Artiva Biotherapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
